Search

Search bills, members, committees and pages...

Sign In

Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.

Hearing•House Energy and Commerce Subcommittee on Health•Jul 15, 2026 · 10:15 AM

Summary

House Energy and Commerce Subcommittee on Health held a hearing on Jul 15, 2026 at 10:15 AM in Rayburn House Office Building, Room 2123. 5 witnesses appeared.

Record

The meeting has its video, witnesses and documents on the record.

Video

The proceedings, as the committee streamed them.

Witnesses

5 witnesses appeared, with 20 papers on file.

NamePositionPapers
Dr. Cynthia VerstPresident, Design and Delivery Innovation, R&D Solutions, IQVIABiography · Truth in Testimony · Testimony · Testimony
Ms. Susan WincklerCEO, Reagan-Udall Foundation for the FDABiography · Truth in Testimony · Testimony · Witness Support Document · Witness Support Document
Dr. Aaron KowalskiCEO, Breakthrough T1DBiography · Truth in Testimony · Testimony · Witness Support Document
Dr. Thomas HwangAssistant Professor of Medicine, Brigham and Women's Hospital and Harvard Medical SchoolBiography · Witness Support Document · Truth in Testimony · Testimony
Mr. Thomas BollykyBloomberg Chair in Global Health, Senior Fellow for International Economics, Law, and Development; and Director of the Global Health Program, CouncilBiography · Testimony · Truth in Testimony

Documents

The committee filed 9 documents for the meeting.

DocumentKindFormat
Hearing NoticeHearing: Cover PagePDF
Hearing MemorandumSupport DocumentPDF
Statement by the Honorable Brett GuthrieMember StatementsPDF
Statement by the Honorable H. Morgan GriffithMember StatementsPDF
Member AttendanceHearing: Member RosterPDF
Majority Staff AttendanceSupport DocumentPDF
Statement by the Honorable Diana DeGetteMember StatementsPDF
Statement by the Honorable Frank Pallone, Jr.Member StatementsPDF
Minority Staff AttendanceSupport DocumentPDF